Jung, H. A., Woo, S. Y., Lee, S., Ahn, J. S., Ahn, M., Park, K., & Sun, J. (2020). The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer. Transl Lung Cancer Res.

Jung, Hyun Ae, Sook Young Woo, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, and Jong-Mu Sun. "The Different Central Nervous System Efficacy Among Gefitinib, Erlotinib and Afatinib in Patients With Epidermal Growth Factor Receptor Mutation-positive Non-small Cell Lung Cancer." Transl Lung Cancer Res 2020.

Jung, Hyun Ae, et al. "The Different Central Nervous System Efficacy Among Gefitinib, Erlotinib and Afatinib in Patients With Epidermal Growth Factor Receptor Mutation-positive Non-small Cell Lung Cancer." Transl Lung Cancer Res 2020.